会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明授权
    • Apparatus and method for treating a tachyarrhythmia
    • 用于治疗快速性心律失常的装置和方法
    • US5458619A
    • 1995-10-17
    • US159351
    • 1993-11-29
    • Walter H. Olson
    • Walter H. Olson
    • A61N1/362A61N1/39
    • A61N1/3962A61N1/3621A61N1/3987
    • An antitachyarrhythmia device employing a tachycardia termination methodology in which antitachycardia pacing and cardioversion pulse therapies are combined. After detection of an arrhythmia which would normally result in delivery of a cardioversion or defibrillation pulse, the device begins to charge high voltage output capacitors. During the charging period, the device deliveries an antitachycardia pacing pulse regimen, in an attempt to terminate the arrhythmia prior to delivery of the cardioversion or defibrillation pulse. Following delivery of the antitachycardia pacing pulse regimen, the device evaluates the heart rhythm to determine whether the tachyarrhythmia has terminated. If so, delivery of a high voltage cardioversion or defibrillation pulse is aborted. If the tachyarrhythmia has not terminated, the high voltage pulse is delivered.
    • 采用心动过速起搏方法的抗心律失常装置,其中结合抗心动过速起搏和心律转复脉冲疗法。 在检测到通常导致心脏复律或除颤脉冲的传递的心律失常之后,器件开始对高电压输出电容器充电。 在充电期间,该装置输送抗心动过速起搏脉冲方案,以试图在输给复律或除颤脉冲之前终止心律失常。 在提供抗心律失调起搏脉搏方案后,该装置评估心律,以确定是否终止快速性心律失常。 如果是这样,中止高压复律或除颤脉冲的输送。 如果快速性心律失常尚未终止,则传送高电压脉冲。
    • 34. 发明授权
    • Method and apparatus for using an optical hemodynamic sensor to identify an unstable arrhythmia
    • 使用光学血液动力学传感器来识别不稳定心律失常的方法和装置
    • US07787947B2
    • 2010-08-31
    • US11394477
    • 2006-03-31
    • Sourav BhuniaWalter H. OlsonCan Cinbis
    • Sourav BhuniaWalter H. OlsonCan Cinbis
    • A61N1/00
    • A61B5/14542A61B5/1459A61N1/3621A61N1/36557A61N1/3956
    • A medical device identifies a hemodynamically unstable arrhythmia based upon optical hemodynamic sensor signals. The optical hemodynamic sensor includes a light source for transmitting light corresponding to first and second wavelengths through a blood perfused tissue of a patient and a light detector for generating optical signals corresponding to an intensity of the detected light at the first and second wavelengths. At a low motion period for the patient, optical signals are obtained from the optical hemodynamic sensor and are analyzed to determine a baseline motion level for the patient. Subsequent signals obtained from the optical hemodynamic sensor are compared to the baseline motion levels, with only those signals corresponding to periods where motion does not exceed the baseline level of motion being further analyzed to determine if they are consistent with a hemodynamically unstable arrhythmia.
    • 医疗设备基于光学血液动力学传感器信号识别血液动力学不稳定的心律失常。 光学血液动力学传感器包括用于通过患者的血液灌注组织透射与第一和第二波长相对应的光的光源,以及用于产生与第一和第二波长的检测光的强度对应的光信号的光检测器。 在患者的低运动周期中,从光学血液动力学传感器获得光学信号,并且被分析以确定患者的基线运动水平。 将从光学血液动力学传感器获得的后续信号与基线运动水平进行比较,只有那些对应于运动未超过基线运动水平的周期的信号进行进一步分析,以确定它们是否与血液动力学不稳定的心律失常一致。
    • 35. 发明授权
    • Subcutaneous cardioverter-defibrillator
    • 皮下心律转复除颤器
    • US07684864B2
    • 2010-03-23
    • US11116577
    • 2005-04-28
    • Walter H. OlsonKing Y. MoyJoey G. NakayamaGary F. ProkopGary J. Stilwell
    • Walter H. OlsonKing Y. MoyJoey G. NakayamaGary F. ProkopGary J. Stilwell
    • A61N1/02
    • A61N1/3968A61N1/0504A61N1/375A61N1/3756
    • SubQ ICDs are disclosed that are entirely implantable subcutaneously with minimal surgical intrusion into the body of the patient and provide distributed cardioversion-defibrillation sense and stimulation electrodes for delivery of cardioversion-defibrillation shock and pacing therapies across the heart when necessary. Configurations include one hermetically sealed housing with 1 or, optionally, 2 subcutaneous sensing and cardioversion-defibrillation therapy delivery leads or alternatively, 2 hermetically sealed housings interconnected by a power/signal cable. The housings are generally dynamically configurable to adjust to varying rib structure and associated articulation of the thoracic cavity and muscles. Further the housings may optionally be flexibly adjusted for ease of implant and patient comfort.
    • 公开了SubQ ICD,其完全可植入皮下,以最小的手术侵入患者身体,并提供分布式心脏复律除颤感和刺激电极,用于在需要时在整个心脏中递送心脏复律除颤电击和起搏治疗。 配置包括一个密封的外壳,具有1个或任选地2个皮下感测和心脏复律除颤治疗输送引线,或者备选地,通过电源/信号电缆互连的2个气密密封外壳。 这些外壳通常是可动态配置的,以适应胸部结构和胸腔和肌肉关联的变化。 此外,为了便于植入和患者舒适,还可以灵活地调整这些外壳。
    • 36. 发明授权
    • Subcutaneous implantable cardioverter/defibrillator
    • 皮下植入式心律转复除颤器
    • US07383085B2
    • 2008-06-03
    • US11419284
    • 2006-05-19
    • Walter H. Olson
    • Walter H. Olson
    • A61N1/39
    • A61N1/3622A61N1/0563A61N1/375A61N1/3918A61N1/3956A61N1/3968A61N1/3981
    • Implantable cardioverter-defibrillators (ICDs) are disclosed that are entirely implantable subcutaneously with minimal surgical intrusion into the body of the patient and provide distributed cardioversion/defibrillation and pace/sense electrodes for delivery of cardioversion/defibrillation shock and pacing therapies across the heart when necessary. At least two hermetically sealed housings forming first and second hermetically sealed housings coupled together by a cable support first, second and, optionally, third cardioversion/defibrillation electrodes. The relatively bulky high voltage battery and high voltage capacitors, and circuitry powered by a low voltage power source for detecting a tachyarrhythmia, charging the high voltage capacitor, and discharging the high voltage capacitor to provide a cardioversion/defibrillation shock are distributed between the first and second hermetically sealed housings.
    • 公开了植入式心律转复除颤器(ICD),其完全可植入皮下,以最小的手术入侵患者身体,并提供分布式心脏复律/除颤和步调/感应电极,用于在需要时在整个心脏递送心脏复律/除颤休克和起搏疗法 。 至少两个气密密封的壳体形成第一和第二密封壳体,其通过电缆支撑件第一,第二以及任选的第三心电复律/除颤电极耦合在一起。 相对庞大的高电压电池和高压电容器以及由用于检测快速性心律失常的低压电源供电的电路,对高压电容器充电以及对高压电容器进行放电以提供心脏复律/除颤电击分布在第一和 第二个密封的外壳。
    • 38. 发明授权
    • Prioritized rule based method and apparatus for diagnosis and treatment
of arrhythmias
    • 用于诊断和治疗心律失常的优先规则方法和装置
    • US6052620A
    • 2000-04-18
    • US47649
    • 1998-03-25
    • Jeffrey M. GillbergWalter H. Olson
    • Jeffrey M. GillbergWalter H. Olson
    • A61N1/362
    • A61N1/3622A61B5/042A61B5/046A61B5/0464A61B5/7264
    • An implantable anti-tachyarrhythmia device which delivers anti-tachyarrhythmia therapies to a patient's heart in response to detection of tachyarrhythmias. The device defines first criteria indicating the presence of atrial tachycardia and second criteria indicating the presence of atrial fibrillation, and compares the time elapsed since the either the first or second criteria were initially met to a defined time duration. In response to the defined duration having passed and either of the first or second criteria being met, the device triggers delivery of an appropriate anti-tachyarrhythmia therapy. The timer is reset on detection of termination of atrial tachyarrhythmia, but not on failure of the first and second criteria to be met. The first and second criteria are defined such that they can not be concurrently met.
    • 一种可植入的抗快速性心律失常装置,其响应于快速性心律失常的检测而向患者的心脏递送抗快速性心律失常疗法。 该装置定义了指示心房性心动过速存在的第一标准和指示心房颤动存在的第二标准,并且比较了从第一或第二标准开始满足到限定的持续时间之后经过的时间。 响应于已经通过的限定的持续时间并满足第一或第二标准中的任一个,该装置触发适当的抗快速性心律失常治疗的递送。 在检测到心房性心律失常终止时,定时器复位,但不符合第一和第二标准的失败。 第一和第二个标准被定义为不能同时满足。